AXA S.A. - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 154 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
AXA S.A. ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$669,820
+132.2%
31,300
+404.8%
0.00%
+100.0%
Q4 2022$288,424
-55.2%
6,200
-50.0%
0.00%0.0%
Q3 2022$643,594
-88.3%
12,400
-90.1%
0.00%
-87.5%
Q2 2021$5,492,000
+184.4%
124,800
+218.8%
0.01%
+33.3%
Q1 2021$1,931,000
+466.3%
39,147
+383.3%
0.01%
+500.0%
Q4 2020$341,000
-4.5%
8,100
+3.8%
0.00%0.0%
Q3 2020$357,000
-54.5%
7,800
-50.0%
0.00%
-50.0%
Q2 2020$784,000
+235.0%
15,600
+372.7%
0.00%
+100.0%
Q4 2018$234,000
-82.1%
3,300
-78.4%
0.00%
-80.0%
Q3 2018$1,308,000
-35.2%
15,300
-12.1%
0.01%
-37.5%
Q2 2018$2,017,000
+52.6%
17,400
-52.4%
0.01%
+60.0%
Q3 2015$1,322,000
+42.3%
36,590
+20.6%
0.01%
+25.0%
Q1 2015$929,000
-38.7%
30,350
+1.8%
0.00%
-33.3%
Q4 2014$1,515,000
+211.1%
29,800
+142.3%
0.01%
+200.0%
Q3 2014$487,00012,3000.00%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 476,042$45,472,00012.29%
Stonepine Capital Management, LLC 60,840$5,811,0003.34%
ACUTA CAPITAL PARTNERS, LLC 61,000$5,827,0002.77%
Virtus ETF Advisers LLC 10,634$1,016,0002.16%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 61,000$5,827,0002.15%
ARMISTICE CAPITAL, LLC 372,000$35,533,0001.94%
Matarin Capital Management, LLC 209,403$20,002,0001.46%
Monashee Investment Management LLC 50,000$4,776,0001.10%
Granahan Investment Management 151,322$14,454,0000.78%
ALGERT GLOBAL LLC 13,186$1,260,0000.72%
View complete list of ENANTA PHARMACEUTICALS INC shareholders